Aprepitant against pruritus in patients with solid tumours

Supportive Care in Cancer

Volumn 18, Issue 9, 2010, Pages 1229-1230

  Vincenzi, Bruno ^a   Fratto, Maria Elisabetta ^a   Santini, Daniele ^a   Tonini, Giuseppe ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Aprepipant; Neurokinin 1 receptor; Pruritus

Indexed keywords

APREPITANT; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; NEUROKININ 1 RECEPTOR; PREDNISONE; SEROTONIN 3 ANTAGONIST;

ABSENCE OF SIDE EFFECTS; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; CHEMOTHERAPY INDUCED EMESIS; CONSULTATION; DEPRESSION; DERMATOLOGY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; INSOMNIA; MALE; METASTASIS; NAUSEA AND VOMITING; PRIORITY JOURNAL; PRURITUS; RELAPSE; SOFT TISSUE SARCOMA; SOLID TUMOR; VISUAL ANALOG SCALE;

ANTIEMETICS; FEMALE; HUMANS; MALE; MORPHOLINES; NEOPLASMS; PRURITUS; RECEPTORS, NEUROKININ-1;

EID: 77956459887     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-010-0895-9     Document Type: Article

References (5)

1. Navari RM (2009) Antiemetic control: toward a new standard of care for emetogenic chemotherapy. Expert Opin Pharmacother 10 (4):629-644
2. Saito R, Takano Y, Kamiya HO (2003) Roles of substance P and NK (1) receptor in brain stem in the development of emesis. J Pharmacol Sci 91:87-94
3. Reddy GK, Gralla RJ, Hesketh PJ (2006) Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapyinduced emesis. Support Cancer Ther 1 (3):140-142
4. Weldon D (2007) What lies beneath the surface of the itch in adults? Allergy Asthma Proc 28 (2):153-162
5. Duval A, Dubertret L (2009) Aprepitant as an antipruritic agent? N Engl J Med 361 (14):1415-1416